Clinical trial
NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder
NCT00213577 · University Hospital, Rouen, Other · Terminated
Key facts
| NCT number | NCT00213577 |
|---|---|
| Title | NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder |
| Official title | Evaluation of the Efficacy and Tolerance of 2 Dosages of Type A Botulinic Toxin in Neurogenic Areactive Bladder Resistant to Oral Medical Treatment |
| Lead sponsor | University Hospital, Rouen, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug |
| Interventions | type A botulinum toxin |
| Enrollment | 80 |
| Start date | Dec 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 24, 2015 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: